- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 12, Pages 1511
Publisher
MDPI AG
Online
2019-11-26
DOI
10.3390/cells8121511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Goals and targets for personalized therapy for HCC
- (2019) Thomas Couri et al. Hepatology International
- Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD‑1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway
- (2019) Dong Kim et al. Oncology Letters
- An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
- (2019) Rigney E Turnham et al. eLife
- CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
- (2019) Xiu-Yan Huang et al. Frontiers in Oncology
- Cyclin A-cdk1-Dependent Phosphorylation of Bora Is the Triggering Factor Promoting Mitotic Entry
- (2018) Suzanne Vigneron et al. DEVELOPMENTAL CELL
- Inhibitors of phosphodiesterase as cancer therapeutics
- (2018) Ting Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy
- (2018) Man Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
- (2018) William G. Robichaux et al. PHYSIOLOGICAL REVIEWS
- Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway
- (2018) Masaki Hara et al. CANCER SCIENCE
- Upregulation of Epac-1 in Hepatic Stellate Cells by Prostaglandin E 2 in Liver Fibrosis Is Associated with Reduced Fibrogenesis
- (2017) Marlies Schippers et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Rolipram potentiates bevacizumab-induced cell death in human glioblastoma stem-like cells
- (2017) Sara Ramezani et al. LIFE SCIENCES
- miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma cell growth and metastasis
- (2017) Wei Huo et al. FEBS Open Bio
- Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats
- (2016) Nermeen N El-Agroudy et al. BRITISH JOURNAL OF PHARMACOLOGY
- PDE4B as a microglia target to reduce neuroinflammation
- (2016) Damien D. Pearse et al. GLIA
- Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival
- (2016) Mara Massimi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?
- (2016) Luigi Sapio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epac activation sensitizes rat sensory neurons through activation of Ras
- (2016) Behzad Shariati et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Rolipram improves cognition, reduces anxiety- and despair-like behaviors and impacts hippocampal neuroplasticity after transient global cerebral ischemia
- (2016) Lígia Mendes Soares et al. NEUROSCIENCE
- Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
- (2016) Kevin M. Riggle et al. PEDIATRIC BLOOD & CANCER
- The Popeye domain containing protein family – A novel class of cAMP effectors with important functions in multiple tissues
- (2016) Roland F.R. Schindler et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion
- (2015) E. Vitali et al. EXPERIMENTAL CELL RESEARCH
- Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
- (2014) Monalisa F. Azevedo et al. ENDOCRINE REVIEWS
- Synthesis, Biological Evaluation, and Molecular Modeling of New 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-Dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) Related Phosphodiesterase 4D (PDE4D) Inhibitors
- (2014) Chiara Brullo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phosphodiesterase 4D Inhibitors Limit Prostate Cancer Growth Potential
- (2014) Ginny L. Powers et al. MOLECULAR CANCER RESEARCH
- Advances in targeting cyclic nucleotide phosphodiesterases
- (2014) Donald H. Maurice et al. NATURE REVIEWS DRUG DISCOVERY
- Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition
- (2014) Liping Sun et al. PLoS One
- PDE7B Is a Novel, Prognostically Significant Mediator of Glioblastoma Growth Whose Expression Is Regulated by Endothelial Cells
- (2014) Michael D. Brooks et al. PLoS One
- Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression
- (2013) JUAN MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CO2/HCO3−- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor
- (2013) Jonathan H. Zippin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro
- (2013) Jie Yang et al. PEPTIDES
- Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers
- (2013) D.-C. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclic AMP sensor EPAC proteins and energy homeostasis
- (2013) Muayad Almahariq et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation
- (2012) Chris Rundfeldt et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Involvement of PGE2and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages
- (2012) Manuel D. Díaz-Muñoz et al. BIOCHEMICAL JOURNAL
- Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation
- (2012) Eva Vacas et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation
- (2012) M. Ionta et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- cAMP and Epac in the regulation of tissue fibrosis
- (2012) Paul A Insel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin
- (2012) Eri Makinodan et al. EXPERIMENTAL DERMATOLOGY
- Oral Administration of Forskolin and Rutin Contributes to Intraocular Pressure Control in Primary Open Angle Glaucoma Patients Under Maximum Tolerated Medical Therapy
- (2012) Michele Vetrugno et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Enhanced Leptin Sensitivity, Reduced Adiposity, and Improved Glucose Homeostasis in Mice Lacking Exchange Protein Directly Activated by Cyclic AMP Isoform 1
- (2012) J. Yan et al. MOLECULAR AND CELLULAR BIOLOGY
- cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membrane
- (2012) S. V. Consonni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isoform-specific antagonists of exchange proteins directly activated by cAMP
- (2012) T. Tsalkova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses
- (2011) O Bruno et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
- (2011) Thérèse Keravis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
- (2011) Makoto Fukuda et al. Cell Metabolism
- Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis
- (2011) Sarawut Jitrapakdee INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mechanism of Intracellular cAMP Sensor Epac2 Activation
- (2011) Sheng Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways
- (2011) Eun-Yi Moon et al. LIFE SCIENCES
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury
- (2011) Irene Paterniti et al. PLoS One
- Treating brain tumors with PDE4 inhibitors
- (2011) Rajarshi Sengupta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses
- (2011) Heba W. Z. Khella et al. TUMOR BIOLOGY
- Translational control of cyclins
- (2011) Woan-Yuh Tarn et al. Cell Division
- Between Death and Survival: Retinoic Acid in Regulation of Apoptosis
- (2010) Noa Noy Annual Review of Nutrition
- Exchange Protein Directly Activated by Cyclic AMP Increases Melanoma Cell Migration by a Ca2+-Dependent Mechanism
- (2010) E. Baljinnyam et al. CANCER RESEARCH
- Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
- (2010) Therese Keravis et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNA control of signal transduction
- (2010) Masafumi Inui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epac increases melanoma cell migration by a heparan sulfate-related mechanism
- (2009) Erdene Baljinnyam et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Epac inhibits migration and proliferation of human prostate carcinoma cells
- (2009) M Grandoch et al. BRITISH JOURNAL OF CANCER
- Targeting cancer with phosphodiesterase inhibitors
- (2009) Rajkumar Savai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- H89, an inhibitor of PKA and MSK, inhibits cyclic-AMP response element binding protein-mediated MAPK phosphatase-1 induction by lipopolysaccharide
- (2009) Il Je Cho et al. INFLAMMATION RESEARCH
- Mechanism of Epac Activation
- (2009) Tamara Tsalkova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades
- (2009) Uma Kant Misra et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- New Selective Phosphodiesterase 4D Inhibitors Differently Acting on Long, Short, and Supershort Isoforms
- (2009) Olga Bruno et al. JOURNAL OF MEDICINAL CHEMISTRY
- PDE4 inhibitors: current status
- (2008) D Spina BRITISH JOURNAL OF PHARMACOLOGY
- Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
- (2008) P. Goldhoff et al. CLINICAL CANCER RESEARCH
- Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B
- (2008) Holger Rehmann et al. NATURE
- Antiproliferative Effects of CC-8062 and CC-8075 in Pancreatic Cancer Cells
- (2008) Petros X.E. Mouratidis et al. PANCREAS
- Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
- (2008) Olga A. H. Reneerkens et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More